When was Endo founded?

Endo was founded in 1997 and raised its 1st funding round within a year of its incorporation.

Where is Endo located?

Endo is headquartered in Malvern, United States. It is registered at 9/215, PUDUPAKKAM-VANDALUR MAIN ROAD PUDUPAKKAM, KELAMBAKKAM, Chennai, CHENNAI, Tamil Nadu, India, 603103.

How many employees does Endo have?

As of Aug 31, 2026, the latest employee count at Endo is 1434.

Is Endo a funded company?

Endo is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Unattributed round, raised on 1997.

When was the latest funding round of Endo?

Endo's latest funding was a $***** Post IPO round on Mar 21, 2024, with participation from 0 investor.

What is the annual revenue of Endo?

Annual revenue of Endo is more than $1B as on Dec 31, 2023

Where does Endo rank among its competitors?

Endo ranks 42nd amongst 1835 active competitors, of which 94 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Endo?

Endo's top competitors include AbbVie, Gilead and Amgen. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Endo - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Website: www.endo.com
Registered Address: 9/215, PUDUPAKKAM-VANDALUR MAIN ROAD PUDUPAKKAM, KELAMBAKKAM, Chennai, CHENNAI, Tamil Nadu, India, 603103

Key Metrics

Founded Year

1997

Location

Malvern, United States

Stage

Public

Latest Funding Round

Post IPO, Mar 21, 2024, $*****

Investors

Paulson & Co & 4 more

Ranked

42^nd among 1835 active competitors

Annual Revenue

$1B+ as on Dec 31, 2023

Employee Count

1,434 as on Aug 31, 2026

Investment & Acquisitions

BioSpecifics Technologies & 15 more

Similar Companies

AbbVie & 1863 more

Exit Details

Public

View Endo's full profile

Endo is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ENDO INTERNATIONAL PLC CIN: 1593034 , United States, Active		$1B+ (As on Dec 31, 2023)	2861 (As on Feb 28, 2023)	-
PAR FORMULATIONS PRIVATE LIMITED CIN: U33111TN1982PTC009602 , India, Active	Sep 22, 1982	₹1,000+ Cr (As on Mar 31, 2025)	1431 (As on Sep 30, 2024)

Endo got listed on Mar 07, 2014.

Click here to take a look at Endo's IPO in detail

Endo has raised funding over 3 rounds. Its first funding round was on 1997. Endo has 5 institutional investors.

Here is the list of recent funding rounds of Endo:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 21, 2024	7436560	Post IPO	5669132	6759623	5356760	5984878
Feb 07, 2011	8886803	Grant (prize money)	1928108	3229098	2324755	HHS
1997	2752	Unattributed	5058	3724	8300	Kelso & Company

Access funding benchmarks and valuations. Sign up today!

View details of Endo's funding rounds and investors

Endo's employee count trend

Endo has 1,434 employees as of Aug 26. Here is Endo's employee count trend over the years:

Uncover Endo's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Endo include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of Endo, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 9 others	83/100
2nd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal ventures & 17 others	81/100
3rd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	79/100
4th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	76/100
5th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
6th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	74/100
7th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	72/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 11 others	70/100
10th	Genentech 1976, San Francisco (United States), Acquired	R&D company focused on manufacturing drugs for multiple therapeutic areas	$72.5M	Ignite 500, The Column Group & 4 others	68/100
42nd	Endo 1997, Malvern (United States), Public	Global pharmaceutical company manufacturing branded, generic formulations, and OTC medicines	-	Paulson & Co, Signet Healthcare Partners & 3 others	60/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Endo's competitors? Click here to see the top ones

Endo has made 1 investments in companies including Cecelia Health. Endo has also acquired 15 companies including BioSpecifics Technologies and Somerset Therapeutics.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Oct 19, 2020	Acquisition	BioSpecifics Technologies	1957	Lynbrook (United States)
Aug 06, 2020	Investments	Cecelia Health	2009	New York City (United States)
Apr 25, 2018	Acquisition	Somerset Therapeutics	2015	Somerset (United States)